DD215539A5 - Verfahren zur herstellung neuer substituierter pyrrolidinderivate - Google Patents

Verfahren zur herstellung neuer substituierter pyrrolidinderivate Download PDF

Info

Publication number
DD215539A5
DD215539A5 DD84259604A DD25960484A DD215539A5 DD 215539 A5 DD215539 A5 DD 215539A5 DD 84259604 A DD84259604 A DD 84259604A DD 25960484 A DD25960484 A DD 25960484A DD 215539 A5 DD215539 A5 DD 215539A5
Authority
DD
German Democratic Republic
Prior art keywords
hydrogen
formula
compound
radical
substituted
Prior art date
Application number
DD84259604A
Other languages
German (de)
English (en)
Inventor
William Bencze
Bruno Kamber
Angelo Storni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD215539A5 publication Critical patent/DD215539A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DD84259604A 1983-01-27 1984-01-25 Verfahren zur herstellung neuer substituierter pyrrolidinderivate DD215539A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH45483 1983-01-27

Publications (1)

Publication Number Publication Date
DD215539A5 true DD215539A5 (de) 1984-11-14

Family

ID=4187392

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84259604A DD215539A5 (de) 1983-01-27 1984-01-25 Verfahren zur herstellung neuer substituierter pyrrolidinderivate

Country Status (12)

Country Link
EP (1) EP0115473A3 (enrdf_load_stackoverflow)
JP (1) JPS59141544A (enrdf_load_stackoverflow)
KR (1) KR840007570A (enrdf_load_stackoverflow)
AU (1) AU2383984A (enrdf_load_stackoverflow)
DD (1) DD215539A5 (enrdf_load_stackoverflow)
DK (1) DK35984A (enrdf_load_stackoverflow)
FI (1) FI840261A7 (enrdf_load_stackoverflow)
GR (1) GR81747B (enrdf_load_stackoverflow)
IL (1) IL70791A0 (enrdf_load_stackoverflow)
NO (1) NO840311L (enrdf_load_stackoverflow)
PT (1) PT78008B (enrdf_load_stackoverflow)
ZA (1) ZA84595B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021568A (en) * 1988-04-22 1991-06-04 Shipov Alexandr G Lactam-1-acetic acid carbalkoxymethyl esters and method for preparing same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
JP2997488B2 (ja) * 1989-12-25 2000-01-11 興研株式会社 腫瘍細胞増殖抑制剤
JP2024538670A (ja) * 2021-09-30 2024-10-23 プロティニ ビー．ブイ． プロテアーゼ阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins
GB1539817A (en) * 1976-10-22 1979-02-07 Ucb Sa N-substituted lactams
US4254107A (en) * 1979-11-27 1981-03-03 Merck & Co., Inc. Long-lasting agonists of enkephalin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021568A (en) * 1988-04-22 1991-06-04 Shipov Alexandr G Lactam-1-acetic acid carbalkoxymethyl esters and method for preparing same

Also Published As

Publication number Publication date
EP0115473A3 (de) 1987-01-21
IL70791A0 (en) 1984-04-30
FI840261A7 (fi) 1984-07-28
GR81747B (enrdf_load_stackoverflow) 1984-12-12
DK35984D0 (da) 1984-01-26
KR840007570A (ko) 1984-12-08
AU2383984A (en) 1984-08-02
ZA84595B (en) 1984-11-28
EP0115473A2 (de) 1984-08-08
DK35984A (da) 1984-07-28
NO840311L (no) 1984-07-30
FI840261A0 (fi) 1984-01-23
PT78008A (en) 1984-02-01
PT78008B (en) 1986-06-18
JPS59141544A (ja) 1984-08-14

Similar Documents

Publication Publication Date Title
EP0184550B1 (de) 5-Amino-4-hydroxyvalerylamid-Derivate
DE69400798T2 (de) Urethane und Urea zur Induktion der Cytokin-Produktion
EP0197478B1 (de) Neue Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0119161B1 (de) Gewisse Benzazocinon- und Benzazoninon-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
CH676988A5 (enrdf_load_stackoverflow)
CH677672A5 (enrdf_load_stackoverflow)
DD217807A5 (de) Verfahren zur herstellung neuer substituierter tetrapeptide
EP0169812B1 (de) Phosphatidylverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4443390A1 (de) Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
DD216005A5 (de) Verfahren zur herstellung von pyrrolidinonderivaten
DE3628650A1 (de) Renininhibitoren, verfahren zur herstellung und ihre verwendung
DD283807A5 (de) Verfahren zur herstellung von cycloalkyl-substituierten glutaramid-derivaten
EP0144290A2 (de) Substituierte Aethylendiaminderivate
DD215539A5 (de) Verfahren zur herstellung neuer substituierter pyrrolidinderivate
EP0233837A2 (de) Saccharidderivate und Verfahren zu ihrer Herstellung
DE60010711T2 (de) Amido-spiropiperidine promovieren die freisetzung von wachstumshormonen
DE69221473T2 (de) Bis-naphthalimide, die amide und thioamide als linker enthalten als krebsmittel
EP0462949A1 (en) 1-alkyl-3-(acylamino)-epsilon-caprolactames as enhancers of learning and memory and pharmaceutical compositions containing same
EP0174912A2 (de) Phosphorverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0403828A1 (de) Renininhibitorische Peptide, Verfahren zur ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE69018816T2 (de) Aminosäurederivate.
DE69027460T2 (de) Peptidderivate und deren pharmazeutische Verwendung
DE3222779C2 (enrdf_load_stackoverflow)
EP0391850B1 (de) Ungesättigte Aminodicarbonsäurederivate
EP0163286A2 (de) Acylierte Zuckerderivate, Verfahren zu ihrer Herstellung und ihre Verwendung